Algiers, November 13, 2025 – Algeria is set to host a pivotal African ministerial conference focusing on the local production of medicines and health technologies. The conference, scheduled to take place in Algiers from November 27th to 29th, promises to be a landmark event for the continent.
The Minister of Pharmaceutical Industry, Wassim Kouideri, announced the details during a press conference held at the Sheraton Hotel in Algiers. He emphasized that the African Ministerial Conference will gather ministers of health, industry, and trade from across Africa, alongside representatives from international and regional organizations, financial institutions, the private sector, and the scientific community.
“This conference represents a significant opportunity to strengthen pharmaceutical sovereignty across the African continent,” stated Minister Kouideri. Discussions will center around strategic themes including enhancing local production of medicines, vaccines, and medical supplies. Furthermore, strategies for technology transfer, the development of shared value chains, improvements to regulatory frameworks, and the facilitation of mutual drug registration between African nations will be addressed. The ultimate goal is to achieve health sovereignty within the continent.
The conference will also feature a pharmaceutical and health technology exhibition, providing Algerian companies with a platform to showcase their products and innovations and explore partnership and investment opportunities, according to the Minister.
Minister Kouideri confirmed that the conference will culminate in the “Algiers Declaration,” which he envisions as a genuine catalyst for African integration, continental pharmaceutical security, and increased trade among African nations.
He further noted that Algeria’s hosting of this important continental event underscores its steadfast commitment to the principles of African solidarity and regional integration, aligning with President Abdelmadjid Tebboune’s vision of a strong, sovereign, united, and collaboratively developed Africa.
The Minister also highlighted the significant progress made in Algeria’s pharmaceutical sector in recent years, including the development of regulatory frameworks, the facilitation of investment, the encouragement of partnerships, and support for pharmaceutical research and development. These efforts, Kouideri explained, have enabled Algeria to cover approximately 82% of its national medicine needs with locally produced pharmaceuticals, with a growing focus on exporting to African markets. He emphasized that this leading national experience serves as a model.
